Access to diabetic peripheral neuropathy screening for underserved communities
Award amount
$284,039Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VisionQuest Biomedical Inc
- Proposal award date
- 2024-09-02
- Contract end date
- 2025-08-31
- UEI
- GLKJYG8H1HS7
- Solicitation number
- PA23-230
- Topic code
- 200
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Automated system to improve compliance to diabetic retinopathy screening
- Thermal Imaging Modality for Detection of Large and Small Fiber Diabetic Peripheral Neuropathy
- EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
- Malarial retinopathy screening system for improved diagnosis of cerebral malaria
- Thermal Imaging Modality for Detection of Large and Small Fiber Diabetic Peripheral Neuropathy.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
- Next-Gen Oral Therapeutics for Type 2 Diabetes
- Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
- Development of novel therapeutics for obesity and type 2 diabetes
- Metrifonate local application for DFU treatment
Research funding history
36 SBIR/STTR records share this UEI (2007–2024). Reported award amounts total $28,343,639. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services